Interpretability of estimands based on mean function regression models for recurrent and terminal events
Investigating treatment effects with complex disease processes is challenging even in randomized trials when interventions can impact several facets of the disease. While intensity-based modeling can provide the greatest insight into the dynamic aspects of such processes, treatment comparisons are typically based on marginal clinically important features. We consider the assessment of treatment effects in clinical trials involving recurrent and terminal events and investigate the determinants of estimands based on mean function regression models with multiplicative covariate effects. The Ghosh-Lin estimator focuses on the cumulative mean number of recurrent events, while the Mao-Lin model is based on a composite recurrent-terminal event outcome. Using a variety of intensity-based models, we investigate the limiting values of the two estimators of treatment effect and make recommendations. An application to a palliative trial of individuals with breast cancer metastatic to bone is provided for illustration.
Authors
- Jerald F. Lawless (ORCID: https://orcid.org/0000-0002-3192-0470)
- Richard J. Cook (ORCID: https://orcid.org/0000-0002-1414-4908)
- Alexandra Bühler (ORCID: https://orcid.org/0000-0002-0872-0374)
Institutions
- University of Waterloo (CA)
Publication Details
- Journal
- Statistical Methods in Medical Research
- Published
- 2026-11-20
- DOI
- https://doi.org/10.1177/09622802261507853
- Primary Topic
- Statistical Methods in Clinical Trials
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Canadian Institutes of Health Research
- Natural Sciences and Engineering Research Council of Canada